Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
13 studies found for:    15111519 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema.
Condition: Efficacy and Safety of Ranibizumab (Lucentis)
Intervention: Drug: Lucentis Intravitreal injections
2 Terminated Evaluation of Single Nucleotide Polymorphisms (SNPs) in Patients With and Without Diabetic Macular Edema
Conditions: Diabetic Retinopathy;   Diabetic Macular Edema
Intervention:
3 Unknown  Analisys of Neuromuscular Response, Postural Balance and Quality of Life of Diabetics Type 2 After Sensory-motor Training: Blind Random Controled Clinical Trial
Conditions: Diabetes Mellitus;   Quality of Life;   Exercise Therapy;   Postural Balance
Intervention: Procedure: sensorio-motor training
4 Completed Effect of DMMET-01 on Insulin Sensitivity in Naive Type 2 Diabetes Patients (CLAMP)
Condition: Diabetes Type 2
Interventions: Drug: DMMET-01;   Drug: Placebo
5 Completed Study on DMMET-01 Versus Metformin on Improvement of Metabolic Control in Naive Type 2 Diabetes Patients
Condition: Diabetes Type 2
Interventions: Drug: DMMET-01;   Drug: Metformin Hydrochloride
6 Unknown  Acute Viral Hepatitis and Diabetes Mellitus
Conditions: Acute Viral Hepatitis;   Diabetes Mellitus
Intervention:
7 Not yet recruiting Aspirin and Renal Disease Progression in Patients With Type 2 Diabetes
Condition: Diabetes
Interventions: Drug: Aspirin;   Other: Placebo
8 Completed Durban Diabetes Study:A Study of the Epidemiology of Diabetes Mellitus in Urban South Africans of African Descent (DDS)
Conditions: Diabetes Mellitus;   Hyperglycemia;   Hereditary Diseases;   Glucose Intolerance
Intervention: Other: blood sample
9 Completed Effects of Linagliptin on Renal Endothelium Function in Patients With Type 2 Diabetes.
Condition: Type 2-diabetes
Interventions: Drug: Linagliptin;   Drug: Placebo
10 Completed Protein Profile of Immunoregulatory Factors in Diabetic Cataract
Conditions: Cataract;   Type 2 Diabetes Mellitus
Intervention: Drug: Ketorolac
11 Completed Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients
Conditions: Diabetes Mellitus Type 2;   Metabolic Syndrome;   Cardiovascular Disease;   Diastolic Dysfunction;   Fatty Liver
Interventions: Drug: Liraglutide;   Drug: Liraglutide - Placebo
12 Completed
Has Results
Efficacy Study of Pioglitazone and Metformin and Association Between Pioglitazone Response and Peroxisome Proliferator-activated Receptor Gamma Gene Variants in Bangladeshi Type 2 Diabetes Mellitus Subjects
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Pioglitazone hydrochloride;   Drug: Metformin hydrochloride
13 Recruiting Assessing Progression to Type-2 Diabetes (APT-2D): A Prospective Cohort Study Expanded From BRITE-SPOT (Bio-bank and Registry for StratIfication and Targeted intErventions in the Spectrum Of Type 2 Diabetes)
Conditions: Pre-diabetes;   Diabetes
Intervention: Procedure: Not applicable. This is an observational study.

Study has passed its completion date and status has not been verified in more than two years.